Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics

Tuberculosis (TB) remains one of the leading causes of death worldwide due to a single infectious disease agent. BCG, the only licensed vaccine against TB, offers limited protection against pulmonary disease in children and adults. TB vaccine research has recently been reinvigorated by new data sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Enriquez, Ana B., Izzo, Angelo, Miller, Shannon M., Stewart, Erica L., Mahon, Robert N., Frank, Daniel J., Evans, Jay T., Rengarajan, Jyothi, Triccas, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572789/
https://www.ncbi.nlm.nih.gov/pubmed/34759923
http://dx.doi.org/10.3389/fimmu.2021.740117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572789/
https://www.ncbi.nlm.nih.gov/pubmed/34759923
http://dx.doi.org/10.3389/fimmu.2021.740117

Ejemplares similares